Vaccinex, Inc. (VCNX)

Oncology Corporate Profile

Stock Performance

1.7700
-0.0400

HQ Location

1895 Mount Hope Avenue
Rochester, NY 14620

Company Description

Vaccinex, Inc. is a privately held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other targeted biological therapies. A Vaccinex antibody product is currently in clinical trials for immunotherapy of cancer and to prevent or delay the onset of neurodegenerative Huntington’s disease.

Website: http://www.vaccinex.com/

This company does not have any commercial products

This company does not have any pipeline products

Source: http://www.vaccinex.com/

Recent News Headlines

There are no news items to display